Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Cincilla

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Molecular Informatics|July 28, 2016
Structuring Chemical Space: Similarity-Based Characterization of the PubChem DatabaseGiovanni Cincilla, Michael Thormann, Miquel Pons
Journal of Computer-Aided Molecular Design|October 10, 2008
An improved scoring function for suboptimal polar ligand complexesGiovanni Cincilla, David Vidal, Miquel Pons
Journal of Cheminformatics|October 12, 2021
Individual and collective human intelligence in drug design: evaluating the search strategyGiovanni Cincilla, Simone Masoni, Jascha Blobel
Journal of Medicinal Chemistry|August 10, 2022
Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in MiceNora Khiar-Fernández, Debora Zian, Henar Vázquez-Villa, et al.
Journal of Medicinal Chemistry|August 31, 2022
2-(Fluoromethoxy)-4'-(<i>S</i>-methanesulfonimidoyl)-1,1'-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for Parkinson's DiseaseJavier García-Cárceles, Henar Vázquez-Villa, José Brea, et al.
Journal of Medicinal Chemistry|December 3, 2019
A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA<sub>1</sub>), UCM-05194, Shows Efficacy in Neuropathic Pain AmeliorationInés González-Gil, Debora Zian, Henar Vázquez-Villa, et al.
Journal of Medicinal Chemistry|November 8, 2021
An Open Drug Discovery Competition: Experimental Validation of Predictive Models in a Series of Novel AntimalarialsEdwin G Tse, Laksh Aithani, Mark Anderson, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Molecular Informatics|July 28, 2016
Structuring Chemical Space: Similarity-Based Characterization of the PubChem DatabaseGiovanni Cincilla, Michael Thormann, Miquel Pons
Journal of Computer-Aided Molecular Design|October 10, 2008
An improved scoring function for suboptimal polar ligand complexesGiovanni Cincilla, David Vidal, Miquel Pons
Journal of Cheminformatics|October 12, 2021
Individual and collective human intelligence in drug design: evaluating the search strategyGiovanni Cincilla, Simone Masoni, Jascha Blobel
Journal of Medicinal Chemistry|August 10, 2022
Novel Antagonist of the Type 2 Lysophosphatidic Acid Receptor (LPA<sub>2</sub>), UCM-14216, Ameliorates Spinal Cord Injury in MiceNora Khiar-Fernández, Debora Zian, Henar Vázquez-Villa, et al.
Journal of Medicinal Chemistry|August 31, 2022
2-(Fluoromethoxy)-4'-(<i>S</i>-methanesulfonimidoyl)-1,1'-biphenyl (UCM-1306), an Orally Bioavailable Positive Allosteric Modulator of the Human Dopamine D<sub>1</sub> Receptor for Parkinson's DiseaseJavier García-Cárceles, Henar Vázquez-Villa, José Brea, et al.
Journal of Medicinal Chemistry|December 3, 2019
A Novel Agonist of the Type 1 Lysophosphatidic Acid Receptor (LPA<sub>1</sub>), UCM-05194, Shows Efficacy in Neuropathic Pain AmeliorationInés González-Gil, Debora Zian, Henar Vázquez-Villa, et al.
Journal of Medicinal Chemistry|November 8, 2021
An Open Drug Discovery Competition: Experimental Validation of Predictive Models in a Series of Novel AntimalarialsEdwin G Tse, Laksh Aithani, Mark Anderson, et al.
Pageof 1